Medpace Holdings (MEDP) Free Cash Flow Growth (3y) (2018 - 2026)
Medpace Holdings (MEDP) Free Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -7.47% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 53.76% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 14.16% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 23.11% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 5.89% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.16% |
| 10 | Medpace Holdings | 17.20 Bn | 16.70 Bn | 201.64 Mn | 23.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.08% |
| Mar 31, 2026 | 27.13% |
| Dec 31, 2025 | 13.86% |
| Sep 30, 2025 | 32.47% |
| Jun 30, 2025 | 18.58% |
| Mar 31, 2025 | 46.29% |
| Dec 31, 2024 | 43.62% |
| Sep 30, 2024 | 28.22% |
| Jun 30, 2024 | 22.19% |
| Mar 31, 2024 | 42.55% |
| Dec 31, 2023 | 14.43% |
| Sep 30, 2023 | 27.41% |
| Jun 30, 2023 | 28.46% |
| Mar 31, 2023 | 17.42% |
| Dec 31, 2022 | 35.54% |
| Sep 30, 2022 | 20.34% |
| Jun 30, 2022 | 25.55% |
| Mar 31, 2022 | 5.53% |
| Dec 31, 2021 | 19.73% |
| Sep 30, 2021 | 9.74% |